Literature DB >> 22839423

Cholestatic hepatic injury due to a thyroid storm: a case report from a resource limited setting.

Davis Kibirige1, Daniel Sekikubo Kiggundu, Richard Sanya, Edrisa Mutebi.   

Abstract

INTRODUCTION: Thyroid storm is an endocrinological emergency caused by an exacerbation of the hyperthyroid state and is characterized by multi organ dysfunction. Liver dysfunction or injury predominantly of a cholestatic type is one of the atypical manifestations of thyroid storm and has been previously described in literature. However, there have been few published case reports among African patients and from resource limited settings. CASE REPORT: We report a case of a 21 year old Ugandan female patient who presented with a thyroid storm due to untreated Graves' disease complicated by cholestatic hepatic injury, congestive heart failure and acute kidney injury.
CONCLUSION: This case highlights the varied multi organ dysfunctions seen in a patient with thyroid storm with emphasis on liver injury mainly to increase awareness among clinicians in resource limited settings. Mechanisms of liver injury due to thyroid storm or hyperthyroidism are discussed in the literature review.

Entities:  

Year:  2012        PMID: 22839423      PMCID: PMC3475043          DOI: 10.1186/1756-6614-5-6

Source DB:  PubMed          Journal:  Thyroid Res        ISSN: 1756-6614


Introduction

Thyroid storm refers to the sudden onset of life-threatening manifestations of hyperthyroidism. Usually, it complicates Graves’ disease but can also occur in association with toxic multinodular goitre [1]. The condition is often evoked by a precipitating factor such as untreated hyperthyroidism, infectious diseases, acute trauma, thyroidal surgery, excessive iodine intake in diet and administration of iodine-containing materials like amiodarone. The clinical picture is predominated mainly by fever, tachycardia or supraventricular arrhythmias, central nervous system symptoms like severe agitation and altered mentation and gastrointestinal symptoms [2]. Hepatic injury as part of the multi organ dysfunction due to thyroid storm has been described in several case reports and in literature ranging from severe liver dysfunction to acute liver failure and resultant death. A cholestatic picture mainly predominates [3-6].

Case report

A 21 year old female patient, newly diagnosed with Graves’ disease was referred from a peripheral hospital with a two week history of progressive yellowing of the eyes associated with generalised abdominal distension, marked right hypochondrial pain and mild generalised pruritis. Ten days prior to her admission, she developed worsening exertional dyspnea, easy fatigability, bilateral lower limb swelling , palpitations, orthopnea , profound weight loss and generalised muscular weakness and heat intolerance. She had been amenorrheic for 4 months and was not taking any medications. She had no history of smoking or alcohol consumption. Clinical examination on admission revealed a thin, diaphoretic and mildly agitated lady. Her axillary temperature was 39.2°C. She had jaundice with bilateral pitting lower limb oedema, a fine resting tremor, exophthalmos and eyelid lag. The thyroid gland was palpable, diffusely enlarged and non tender with a bruit. Cardiovascular examination revealed a rapid, large volume and regular pulse of 140 beats/min with an isolated systolic hypertension of 150/70 mmHg. The jugular venous pressure was raised and neck veins engorged. She had a heaving apex beat displaced to the 6th intercostal space anterior axillary line with a gallop and a soft apical systolic murmur. Abdominal and respiratory examinations revealed a tender hepatomegaly with ascites and reduced breathe sounds on the right infra axillary and scapular areas respectively. A chest radiograph done revealed a cardiomegaly with a right sided pleural effusion. An abdominal Ultra sound scan done showed an enlarged liver with a normal echo texture, ascites, normal biliary ducts and gall bladder. A thyroid ultra sound scan was not done. Electrocardiography showed sinus tachycardia, with a rate of 142 beats/min and left ventricular hypertrophy by voltage criteria. The Echocardiography showed globally dilated cardiac chambers with moderate mitral and tricuspid regurgitation, an elevated ejection fraction of 82% (40-70%) and moderate pulmonary hypertension. The laboratory investigations done are summarised in Table 1 below.
Table 1

Laboratory investigations of the patient

LABORATORY PARAMETERPATIENT’S VALUENORMAL RANGE
1.Total white blood cell count (x109)
8.7
4.0-9.0
2.Absolute Neutrophil count (x109)
6.6
1.7-7.7
3. Haemoglobin level (g/dl)
8.0
12-17
4.Serum albumin (g/l)
21.4
35-50
5. Corrected Calcium (mg/dl)
11.2
9-10.6
6. Alanine transaminase (U/L)
17.9
0-40
7. Aspartate transaminase (U/L)
48.2
0-40
8.Alkaline Phosphatase (U/L)
212
40-129
9.Gamma-glutamyl transpeptidase (U/L)
82.4
0-55
9.Total bilirubin (μmol/l)
233.2
0-40
10.Direct bilirubin (μmol/l)
215.75
0-3.4
11.Serum urea (mmol/l)
12.4
2.7-6.4
12. Serum creatinine (μmol/l)
120.7
44-106
13. Urea/Creatinine ratio
56.4
< 20
14. Serum Sodium (mmol/l)
130
135-150
15. Serum Creatinine kinase (U/L)
815
26-308
16. Serum lactate dehydrogenase (U/L)
409
135-225
17. Serum creatinine kinase-MB isoform-CK-MB (U/L)
100.9 U/L
0-25
18. Random blood sugar (mg/dl)
7.4 mmol/l
3.5-11
19. Urine pregnancy test
Negative.
 
20. HIV serology, Hepatitis Bs Ag test, Hepatitis C antibodiesNegative. 
Laboratory investigations of the patient Thyroid function tests revealed a suppressed thyroid stimulating hormone level (TSH) of <0.005 uIUml (0.27–4.2), raised free thyroxine levels of 267.5 nmol/L (normal range: 66–181) and free triiodothyronine of 10 nmol/L (normal range: 1.3-3.1). A thyroid nuclear scan showed a diffuse homogenous increased uptake of radioactive iodine with no background uptake. Thyroid stimulating hormone receptor antibody, Antithyroglobulin and antithyroid peroxidase antibodies were not done due to financial constraints. An impression of thyroid storm due to untreated Graves’ disease with cholestatic liver injury, high output congestive heart failure due to thyrotoxic heart disease and acute kidney injury was made. The patient’s Burch-Wartofsky score for thyroid storm was 90 [7]. She was started on oral carbimazole, Prednisolone, Propranolol, Lugol’s iodine, intra venous fluid replacement, oral anti histamines for the pruritis, oral frusemide and Captopril for the heart failure. The patient was discharged 10 days later with great improvement and on a follow-up assessment 10 weeks later; she was feeling generally well with resolution of the jaundice and clinically euthyroid. A repeat electrocardiography, echocardiography, renal and liver function tests were all normal.

Discussion

Thyroid storm is a sudden, life-threatening exacerbation of thyrotoxicosis that is associated with multi organ dysfunction and increased mortality if untreated. Possible mechanisms responsible for progression to thyroid storm include a steady increase of tissue iodothyronine levels, an augmented cellular response to the circulating thyroid hormones and their effect of enhancing cellular expression of adrenoceptors and sensitivity to circulating cathechoamines [7,8]. The case reported illustrates a thyroid storm due to untreated Graves’ disease with mainly cardiac, renal and gastrointestinal dysfunctions in a 21 year old girl. The diagnosis of Graves’ disease was made basing on the prominent eye signs (exophthalmos and eyelid lag) and a suggestive thyroid nuclear scan (diffuse homogenous increased uptake of radioactive iodine with no background uptake). Excessive dietary iodine intake is one of the recognised trigger factors of thyroid storm and Graves’ disease [1,2]. However, excessive dietary intake of iodine has been documented to be very uncommon in Uganda. It has been reported in only one district in central Uganda [9]. The patient discussed is from an iodine repleted area with adequate iodine intake in the diet. Causes of liver injury in hyperthyroidism or thyroid storm are multifactorial. A cholestatic type of hepatic injury of centrilobular intrahepatic form predominates as demonstrated in this case. Cholestatic liver injury is mainly depicted by a raised direct hyperbilirubinemia and alkaline phosphatase levels as shown in the patient’s workup. The latter however may signify an increased osteoblastic response to increased thyroid hormone induced bone resorption [10]. Hepatic damage occurring solely due to thyrotoxicosis or hyperthyroidism has also been thought to be due to ischemic injury resulting from a relative decrease in blood flow despite presence of an increased hepatic metabolic activity [10]. Cholestatic liver injury in patients with hyperthyroidism or thyroid storm due to Graves’ disease can also be associated with other pre existing auto immune liver conditions especially primary biliary cirrhosis (PBC) or autoimmune hepatitis. These are seen in up to 10% of patients [11,12]. Other proposed mechanisms of hepatic dysfunction in hyperthyroidism or thyroid storm include hepatic congestion resulting from heart failure due to thyrotoxic heart disease as showed in the case report. This often leads to hepatic abnormalities like acute hepatocellular injury with hyperbilirubinemia and resultant coagulopathy [13,14]. Anti thyroid drugs especially propylthiouracil also cause cholestatic liver injury and the effect is usually dose dependent [15]. However in this patient, we were unable to exclude any intrinsic co-existing auto immune liver conditions due to limitation of resources. The patient declined a liver biopsy.

Conclusion

It is of paramount importance to recognise liver injury due to a thyroid storm or hyperthyroidism and to promptly diagnose and treat thyroid storm especially in resource limited settings where intensive care units aren’t easily accessible. This is because severe liver impairment and thyroid storm are associated with increased mortality.

Consent

Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

DK participated in the care of the patient in the emergency unit and drafted the manuscript. DSK, RS and EM participated in the care of the patient in the endocrinology unit and critically revised the contents of the manuscript. All authors approved the final draft of the manuscript for submission for publication.
  12 in total

Review 1.  Thyroid storm presenting with liver failure.

Authors:  A M Choudhary; I Roberts
Journal:  J Clin Gastroenterol       Date:  1999-12       Impact factor: 3.062

Review 2.  Thyroid emergencies.

Authors:  Nicholas J Sarlis; Loukas Gourgiotis
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 3.  The relationship between the thyroid gland and the liver.

Authors:  R Malik; H Hodgson
Journal:  QJM       Date:  2002-09

Review 4.  Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned?

Authors:  K V Williams; S Nayak; D Becker; J Reyes; L A Burmeister
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

Review 5.  Life-threatening thyrotoxicosis. Thyroid storm.

Authors:  H B Burch; L Wartofsky
Journal:  Endocrinol Metab Clin North Am       Date:  1993-06       Impact factor: 4.741

6.  Two cases of thyroid storm-associated cholestatic jaundice.

Authors:  Kristen Hull; Richard Horenstein; Rosalie Naglieri; Kashif Munir; Marc Ghany; Francesco S Celi
Journal:  Endocr Pract       Date:  2007-09       Impact factor: 3.443

7.  Genetic predispositions for the immunological features of chronic active hepatitis.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

8.  Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations.

Authors:  Robert P Myers; Raimondo Cerini; Raymond Sayegh; Richard Moreau; Claude Degott; Didier Lebrec; Samuel S Lee
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

Review 9.  Hyperthyroidism.

Authors:  David S Cooper
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

10.  Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.

Authors:  Kristien Boelaert; Paul R Newby; Matthew J Simmonds; Roger L Holder; Jacqueline D Carr-Smith; Joanne M Heward; Nilusha Manji; Amit Allahabadia; Mary Armitage; Krishna V Chatterjee; John H Lazarus; Simon H Pearce; Bijay Vaidya; Stephen C Gough; Jayne A Franklyn
Journal:  Am J Med       Date:  2010-02       Impact factor: 4.965

View more
  5 in total

1.  Incidence of abnormal liver biochemical tests in hyperthyroidism.

Authors:  Tiffany Y Lin; Anshula O Shekar; Ning Li; Michael W Yeh; Sammy Saab; Mark Wilson; Angela M Leung
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-09       Impact factor: 3.478

2.  Jaundice: A Thyroid Problem?

Authors:  Chinemerem J Okwara; Amirkaveh Mojtahed; Michael Gavin; Joshua Hanson; Denis McCarthy
Journal:  Dig Dis Sci       Date:  2017-08       Impact factor: 3.199

3.  Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure.

Authors:  Olympia Anastasiou; Svenja Sydor; Jan-Peter Sowa; Paul Manka; Antonios Katsounas; Wing-Kin Syn; Dagmar Führer; Robert K Gieseler; Lars P Bechmann; Guido Gerken; Lars C Moeller; Ali Canbay
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 4.  Challenges in early identification of causes and treatment of cholestasis in patients with hyperthyroidism: a case report and literature review.

Authors:  Baimei Zeng; Ling Yuan; Jun Chu; Yanqing Yang; Shide Lin
Journal:  J Int Med Res       Date:  2019-12-16       Impact factor: 1.671

5.  Cholestatic Hepatitis in Graves' Disease: A Diagnostic Challenge.

Authors:  Metri Haddaden; Angy Hanna; Fadi Odish; Samir Husami; Zaid Imam; Mamon Tahhan
Journal:  ACG Case Rep J       Date:  2021-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.